Balancing External Validity and Concern for Psychosocial Harms in Translational Genetic Research
- 8 March 2021
- journal article
- Published by Wiley in Ethics & Human Research
- Vol. 43 (2), 43-48
- https://doi.org/10.1002/eahr.500086
Abstract
No abstract availableFunding Information
- National Institutes of Health (R01HG009671-01A1, UL1TR002345)
This publication has 22 references indexed in Scilit:
- American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer SusceptibilityJournal of Clinical Oncology, 2015
- Pediatric Professionals' Attitudes about Secondary Findings in Genomic Sequencing of ChildrenThe Journal of Pediatrics, 2015
- Cascade screening based on genetic testing is cost-effective: Evidence for the implementation of models of care for familial hypercholesterolemiaJournal of Clinical Lipidology, 2014
- Human Subjects Protection: An Event Monitoring Committee for Research Studies of Girls From Breast Cancer FamiliesJournal of Adolescent Health, 2014
- Technical report: ethical and policy issues in genetic testing and screening of childrenGenetics in Medicine, 2013
- The Research‐Treatment Distinction: A Problematic Approach for Determining Which Activities Should Have Ethical OversightHastings Center Report, 2013
- Essential Elements of Genetic Cancer Risk Assessment, Counseling, and Testing: Updated Recommendations of the National Society of Genetic CounselorsJournal of Genetic Counseling, 2011
- Effects of genetic risk information on children's psychosocial wellbeing: A systematic review of the literatureGenetics in Medicine, 2010
- The Meaning of Translational Research and Why It MattersJAMA, 2008
- Translational and Clinical Science — Time for a New VisionThe New England Journal of Medicine, 2005